Anticholinergic antimuscarinic agents in the treatment of airways bronchoconstriction in children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 1, 1996, Pages 2-7

  Martinati, L C ^b   Boner, A L ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; OXITROPIUM BROMIDE; SALBUTAMOL;

ASTHMA; BRONCHOSPASM; CLINICAL TRIAL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0029867419     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04542.x     Document Type: Review

References (66)

1. Barnes PJ. Neural control of human airways in health and disease. Am Rev Respir Dis 1986;134:1289-1314.
2. Gross NJ, Barnes PJ. A short tour round the muscarinic receptor. Am Rev Respir Dis 1988;138:765-7.
3. Widdicombe JG, Karlsson JA, Barnes PJ. Cholinergic mechanisms in bronchial hyperreactivity and asthma. In: Kaliner MA, Barnes PJ, Persson CGA, eds. Asthma: its pathology and treatment. New York: Marcel Dekker, 1991;327-56.
4. Gross NJ, Skorodin MS. Anticholinergic antimuscarinic bronchodilators. Am Rev Respir Dis 1984;129:856-70.
5. Skorodin MS, Gross NJ, Moritz T, et al. Oxitropium bromide, a new anticholinergic bronchodilator. Ann Allergy 1986;56:229-32.
6. Engelhardt A, Klupp H. The pharmacology and toxicology of Atrovent. Scand J Respir Dis 1979:103 (Suppl.): 110-15.
7. Lulling J, Delwiche JP, Prignat J. Early bronchodilating effect of oxitropium bromide in comparison with ipratropium bromide. Respiration 1981;42:188-92.
8. Davis A, Vickerson F, Worsley G, Mindorff C, Kazim F, Levison H. Determination of dose-response relationship for nebulized ipratropium bromide in asthmatic children. J Pediatr 1984;105:1002-5.
9. Friberg S, Graff-Lonnevig V. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study. Ann Allergy 1989;62:131-4.
10. Gomm SA, Keaney NP, Hunt LP, Allen SC, Stretton TB. Dose response comparison of ipratropium bromide from metered dose inhaler and by wet nebulization. Thorax 1983;38:297-301.
11. Ulrik CS, Bacher V, Bach Mortensen N. Bronchodilating effect of ipratropium bromide inhalation powder and aerosol in children and adolescents with stable bronchial asthma. Allergy 1992;47:133-7.
12. Van Bever HP, Desager KN, Pauwels JH, Vermiere PA. Comparison of the bronchodilating effect of oxitropium bromide and fenoterol in asthmatic children. Eur J Pediatr 1994;153:604-6.
13. Joppich R. Vergleich der Wirkungen von Reproterol, Oxitropiumbromid, DNCG und Theophyllin auf das Anstrengungs-Asthma bei Kindern. Atemwegs Lungenkr 1987;13:453-6.
14. Neijens HJ, Wesselius TR, Kerrebijn KF. Farmacologische beinvloeding van kortademigheid door inspaning bij kinderen met CARA. Ned Tijdschr Geneeskd 1981;32:1277-81.
15. Peel ET, Anderson G, Cheong B, Broderick N. A comparison of oxitropium bromide and ipratropium bromide in asthma. Eur J Respir Dis 1984;65:106-8.
16. Watson WTA, Beker AB, Simons FER. Comparison of ipratropium solution, fenoterol solution and their combination administered by nebuliser and face mask to children with acute asthma. J Allergy Clin Immunol 1988;82:1012-18.
17. Reisman J, Galdes-Sebalt M, Kazim F, Canny G, Levison H. Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children. J Allergy Clin Immunol 1988;81:16-20.
18. De Stefano G, Bonetti S, Bonizzato C, Valletta EA, Piacentini GL, Boner AL. Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children. Ann Allergy 1990;65:260-2.
19. Delacourt C, De Blic J, Lebourgeois M, Scheinmann P. Intérêt du bromure d'ipratropium dans la crise d'asthme de l'enfant. Arch Pediatr 1994;1:87-92.
20. Greenough A, Yuksel B, Everett L, Price JF. Inhaled ipratropium bromide and terbutaline in asthmatic children. Respir Med 1993;87:111-14.
21. Freeman J, Landau LI. The effects of ipratropium bromide and fenoterol nebulizer solutions in children with asthma. Clin Pediatr 1989;28:556-60.
22. Ros SP. Anticholinergics and the emergency management of bronchial asthma. Pediatr Emerg Care 1988;4:187-8.
23. Beasley CRW, Rafferty P, Holgate ST. Bronchoconstrictor properties of preservative in ipratropium bromide (atrovent) nebulizer solution. Br Med J Clin Res Ed 1987;294:1197-8.
24. Mann NP, Hiller EJ. Ipratropium bromide in children with asthma. Thorax 1982;37:72-4.
25. Bratteby LE, Foucard T, Lonnerholm G. Combined treatment with ipratropium bromide and beta-2 adrenoceptor agonists in childhood asthma. Eur J Respir Dis 1986;68:239-47.
26. Sly PD, Landau LI, Olinsky A. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children. Thorax 1987;42:357-60.
27. Raes M, Mulder P, Kerrebijn KF. Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma. J Allergy Clin Immunol 1989;84:874-9.
28. Hugnes DTD. The use of anticholinergic drugs in nocturnal asthma. Postgrad Med J 1987;63 Suppl. 1:47-51.
29. Sterling GM. Anticholinergic therapy in chronic asthma. Postgrad Med J 1987;63 Suppl. 1:41-6.
30. Boner AL, Vallone G, De Stefano G. Effect of inhaled ipratropium bromide on methacholine and exercise provocation in asthmatic children. Pediatric Pulmonol 1989;6:81-5.
31. Smith CM, Anderson SD, Seale PJ. The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnoea. Chest 1988;94:709-17.
32. Wilson N, Barnes PJ, Vickers H, Silverman M. Hyperventilation induced asthma: evidence for two mechanisms. Thorax 1982;37:657-62.
33. Heaton RW, Henderson AF, Gray BJ, Costello JF. The bronchial response to cold air challenge: evidence for different mechanism in normal and asthmatic subjects. Thorax 1983;38:506-11.
34. Groot CA, Lammers JW, Festen J, van Her Waarden CL. The protective effects of ipratropium bromide and terbutaline on distilled water-induced bronchoconstriction. Pulm Pharmacol 1994;7:59-63.
35. Neijens HJ, Wesselius T, Kerrebijn KF. Exercise induced bronchoconstriction as an expression of bronchial hyperreactivity: a study of its mechanisms in children. Thorax 1981;36:517-22.
36. Wilson NM, Green S, Coe C, Barnes PJ. Duration of protection by oxitropium bromide against cholinergic challenge. Eur J Respir Dis 1987;71:455-8.
37. Prendiville A, Green S, Silverman M. Paradoxical response to salbutamol in wheezy infants. Thorax 1987;42:86-91.
38. Hodges IGC, Groggins RC, Milner AD, Stokes GM. Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers. Arch Dis Child 1981;56:729-32.
39. Henry RL, Hiller EJ, Milner AD, Hodges IGE, Stokes GM. Nebulized ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child 1984;59:54-7.
40. Prendiville A, Green S, Silverman M. Ipratropium bromide and airways function in wheezy infants. Arch Dis Child 1987;62:397-400.
41. Groggings RC, Milner AD, Stokes GM. Bronchodilator effects of clemastine, ipratropium bromide and salbutamol in pre-school children with asthma. Arch Dis Child 1981;56:342-4.
42. Wesley AG, Paruk F, Broughton MH, Gouws E. Ipratropium bromide delivered by metered-dose aerosol to infant wheezers. S Afr Med J 1991;79:536-8.
43. Stokes GM, Milner AD, Hodges IGC, Elphic MC, Henry RI. Nebulized therapy in acute severe bronchitis in infancy. Arch Dis Child 1983;58:279-82.
44. Henry RC, Milner AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983;58:925-6.
45. Schuh S, Johnson D, Canny G, et al. Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics 1992;90:920-3.
46. Milner AD. Ipratropium bromide and airways obstruction in childhood. Postgrad Med J 1987;63 Suppl.1:53-6.
47. Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in ventilator dependent neonates with chronic lung disease. J Pediatr 1987;11:278-82.
48. Kao LC, Durant DJ, Nickerson BG. Effects of inhaled metaproterenol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1989;6:74-80.
49. Silverman M. The role of anticholinergic antimuscarinic bronchodilator therapy in children. Lung 1990;168 Suppl:304-9.
50. Holgate S. Anticholinergics in acute bronchial asthma. Postgrad Med J 1987;63 Suppl 1:35-9.
51. Boner AL, De Stefano G, Niero E, Vallone G, Gaburro D. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children. Ann Allergy 1987;58:54-8.
52. Allen CJ, Campbell AH. Dose response of ipratropium bromide assessed by two methods. Thorax 1980;35:137-9.
53. Ruffin RE, Newhouse MT. Sch. 1000: bronchodilator effect of three dose levels in asthmatics. Lung 1978:155:141-6.
54. Rebuck AS, Chapman KR, Braude AC. Anticholinergic therapy of asthma. Chest 1982;82 (Suppl.):55.
55. Gross NJ, Skorodin MS. Massive overdose of atropine methonitrate with only untoward effects. Lancet 1985:ii:386.
56. Stappaerts I, van Schil L, van der Veken J. Dose-response study of oxitropium bromide inhaled as a nebulized solution. Eur J Clin Pharmacol 1994;46:305-7.
57. Johnson CE. Principles of nebulizer-delivered drug therapy for asthma. Am J Hosp Pharm 1989;46:1845-55.
58. Shenfield GM. Combination bronchodilator therapy: a review article in 2 parts. Med Prog May/June 1983;67-9, 63-75; Part I:76.
59. Barnes PJ, Basbaum CB, Nadel JA. Autoradiographic localization of autonomic receptors in airway smooth muscle: marked differences between large and small airways. Am Rev Respir Dis 1983;127:758-62.
60. Nadel JA, Cabezas GA, Austin JHM. In vivo roentgenographic examination of parasympathetic innervation of small airways: use of powder tantulum and a fine focal spot x-ray. Invest Radiol 1971;6:9-17.
61. Ingram RH, Wellman JJ, McFadden ER, Mead J. Relative contribution of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol. J Clin Invest 1977;59:696-703.
62. Lin MT, Lee-Hong E, Collins-Williams C. A clinical trial of the bronchodilator effect of SCH 1000 aerosol in asthmatic children. Ann Allergy 1978;40:326-32.
63. Partridge MR, Saunders KB. Sites of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma. Thorax 1981;36:530-3.
64. Nizami RM, Chapman KR. Clinical safety of ipratropium bromide. In: Anticholinergic therapy with Atrovent. Toronto Symposium, 1983:39-45.
65. Calverley PM. The clinical efficacy of oxitropium bromide. Rev Contemp Pharmacother 1992;3:189-96.
66. Oxitropium (Oxivent). Drug Ther Bull 1991;29:79-80.